Skip to main content
Fig. 1 | AIDS Research and Therapy

Fig. 1

From: Real-world adherence and persistence for newly-prescribed HIV treatment: single versus multiple tablet regimen comparison among US medicaid beneficiaries

Fig. 1

Study population and cohorts. 3TC lamivudine, ABC abacavir, ATV atazanavir, ATV/c atazanavir boosted with cobicistat, ATV/r atazanavir boosted with ritonavir, COBI cobicistat, DRV darunavir, DRV/r darunavir boosted with ritonavir, DRV/c: darunavir boosted with cobicistat, DTG: dolutegravir; EFV efavirenz, EVG elvitegravir, FTC emtricitabine, RPV rilpivirine, TAF tenofovir alafenamide fumarate, TDF tenofovir disoproxil fumarate

Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us